For the cancer-proven PI-RAD 4 cases, target biopsy was superior to systematic biopsy in 57.7% (30/52) by radiologist A and in 29.5% (23/78) by radiologist B (Table 2) (p = 0.0019). Here, RRAD is linked to cancer.